Summary:
- The article discusses a meeting held by the CDC's Advisory Committee on Immunization Practices (ACIP) to review the hepatitis B vaccine schedule and address concerns raised by the Vaccine Integrity Project.
- The Vaccine Integrity Project has raised questions about the safety and efficacy of the hepatitis B vaccine, particularly for newborns. The ACIP meeting aimed to review the available scientific evidence and determine if any changes to the vaccine schedule are warranted.
- The article highlights the importance of maintaining public trust in vaccine safety and the role of scientific bodies like the ACIP in making evidence-based recommendations to protect public health.